Oruka Therapeutics Surges 10% During Regular Trading on Analyst UpgradesUS Stock Market Update·Jul 17 at 02:40 PMORKA-1.60%
Oruka Therapeutics (ORKA) surges 11% on analyst upgradeUS Stock Market Update·Jul 17 at 12:33 PMORKA-1.60%
Oruka Therapeutics Surges 8% During Regular Trading on Analyst UpgradeUS Stock Market Update·Jul 17 at 09:31 AMORKA-1.60%
Oruka Therapeutics CMO Joana Goncalves disposes of 7,000 common shares for $601,227.73PUBT·Jul 15 at 06:37 PMORKA-1.60%
Oruka Therapeutics SVP Finance Arjun Agarwal sells USD 840,975 in common sharesPUBT·Jul 13 at 04:10 PMORKA-1.60%
Value Capture After the Aggregation Era: The Fragmentation of Specialized NichesGlobal Report·Jul 9 at 09:02 PMBETR-2.96%QUIK-4.58%
Cross-Sector Rotation: AI Monetization Accelerates as Biotech and ADRs Hit Key MilestonesGlobal Report·Jul 9 at 05:03 AMMNSO+8.00%ORKA-1.60%
3 Healthcare Stocks with Strong Upside to Consider in July 2026, According to AnalystsTip Ranks·Jul 3 at 03:22 PMINSM+0.45%BSX+1.78%
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Sharesbenzinga_article·Jul 2 at 01:30 AMORKA-1.60%
Oruka Therapeutics COO Laura Lee Sandler sells USD 472,784 in common sharesPUBT·Jul 1 at 06:58 PMORKA-1.60%
Oruka Therapeutics (ORKA) Is Up 5.1% After Positive Trial Update And Insider Share Sales - What's ChangedSimplywall·Jun 23 at 01:58 PMORKA-1.60%
Oruka Therapeutics SVP Finance Arjun Agarwal disposes of 1,587 common shares worth $127,454.28PUBT·Jun 22 at 07:00 PMORKA-1.60%